Safety of TACE With Oxaliplatin, Irinotecan and Raltitrexed for Refractory Colorectal Cancer Liver Metastasis
NCT02631564 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2015-12-16
Summary
The purpose of this study is to observe whether hepatic infusion by oxaliplatin, irinotecan and raltitrexed with or without embolization by lipiodol or microspheres are effective in the treatment of refratory liver metastasis from colorectal cancer.
Conditions
- Colon Cancer Liver Metastasis
Sponsors & Collaborators
-
Fudan University
lead OTHER
Principal Investigators
-
Bo Zhou, M.D,Ph.D · Shanghai Zhongshan Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-30
- Primary Completion
- 2017-06-30
- Completion
- 2018-12-31
Countries
- China
Study Locations
More Related Trials
-
Compare Efficacy and Safety of Raltitrexed-based and 5fu-based Neoadjuvant Chemotherapy for Colorectal Liver Metastasis
NCT02453490 ·Status: TERMINATED ·Phase: PHASE3
-
Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer
NCT02688023 ·Status: UNKNOWN ·Phase: PHASE2
-
A Prospective Phase II Randomized Clinical Trial of Preoperative Chemotherapy Combined With Short-course Radiotherapy Versus Conventional Neo-adjuvant Therapy for Locally Advanced Rectal Cancer Implemented by MDT
NCT02941562 ·Status: UNKNOWN ·Phase: PHASE2
-
Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal Cancer
NCT02618356 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Target Therapy on Patients Undergoing Synchronic Hepatectomy for Colorectal Liver Metastases
NCT01677728 ·Status: UNKNOWN
-
Perioperative Treatment With TAS-102 in Combination With Oxaliplatin for Locally Advanced Rectal Cancer
NCT07090031 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Short Course Radiotherapy Combined With Chemotherapy in Stage IV Rectal Cancer With Resectable Liver Metastases
NCT02510378 ·Status: UNKNOWN ·Phase: PHASE2
-
Short Course Radiotherapy, Unresectable Rectal Cancer, Liver Metastasis
NCT03022734 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Radiotherapy Combined With Raltitrexed and Irinotecan in Metastatic or Locally Recurrent Colorectal Cancer
NCT04499586 ·Status: UNKNOWN ·Phase: PHASE2
-
TAS-102 Combined With Bevacizumab and Tislelizumab Third-line or Above in the Treatment of Liver Metastasis in Colorectal Cancer
NCT05314101 ·Status: UNKNOWN ·Phase: PHASE2
-
Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver
NCT00030563 ·Status: COMPLETED ·Phase: PHASE2
-
New Adjuvant Chemotherapy of Asymptomatic Resectable Primary Lesion With Unresectable Liver-limited Metastases
NCT01307878 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients
NCT02291744 ·Status: UNKNOWN ·Phase: PHASE2
-
The Value of Palliative Primary Tumor Resection in Metastatic Colon Cancer
NCT04416854 ·Status: RECRUITING ·Phase: PHASE3
-
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
NCT02942563 ·Status: UNKNOWN ·Phase: PHASE2
-
Conversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases
NCT04687631 ·Status: RECRUITING ·Phase: PHASE3
-
The Role and Safety of Radiofrequency Ablation in Recurrent Liver Metastasis of Colorectal Cancer
NCT06609434 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Model for Predicting the Efficacy of Conversion Therapy for Patients With Colorectal Cancer Liver Metastases by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA
NCT03679039 ·Status: UNKNOWN
-
A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer
NCT04543695 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Preoperative Intraarterial Chemoembolization Combined With Radiotherpy in Locally Advanced Rectal Cancer
NCT03601156 ·Status: UNKNOWN ·Phase: NA
-
c-CetuIRI Versus Ersecond-line Irinotecan s-IRI-CetuIRI
NCT04833036 ·Status: UNKNOWN ·Phase: PHASE2
-
TATE and KN046 in MCRC
NCT06834399 ·Status: TERMINATED ·Phase: PHASE2
-
Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases
NCT04525326 ·Status: UNKNOWN ·Phase: PHASE3
-
A Prospective, Safety, and Efficacy Clinical Trial of Pressurized Intraperitoneal Aerosol Therapy for Peritoneal Metastasis of Colorectal Cancer
NCT07349043 ·Status: RECRUITING ·Phase: PHASE1
-
Perioperative Chemotherapy Plus Cetuximab Versus Chemotherapy Alone for High Risk Resectable Colorectal Liver Metastasis
NCT03031444 ·Status: COMPLETED ·Phase: PHASE2/PHASE3